Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation.
Tripodo C, Bassani B, Jachetti E, Cancila V, Chiodoni C, Portararo P, Botti L, Valenti C, Perrone M, Ponzoni M, Comoli P, Lecchi M, Verderio P, Curti A, Colombo MP, Sangaletti S. Tripodo C, et al. Among authors: comoli p. Elife. 2022 Apr 26;11:e69257. doi: 10.7554/eLife.69257. Elife. 2022. PMID: 35471185 Free PMC article.
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D'Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM. Curti A, et al. Among authors: comoli p. Br J Haematol. 2007 Nov;139(3):415-24. doi: 10.1111/j.1365-2141.2007.06832.x. Br J Haematol. 2007. PMID: 17910631 Free article. Clinical Trial.
NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
Forghieri F, Nasillo V, Paolini A, Bettelli F, Pioli V, Giusti D, Gilioli A, Colasante C, Acquaviva G, Riva G, Barozzi P, Maffei R, Potenza L, Marasca R, Fozza C, Tagliafico E, Trenti T, Comoli P, Longo G, Luppi M. Forghieri F, et al. Among authors: comoli p. Int J Mol Sci. 2020 Nov 26;21(23):8975. doi: 10.3390/ijms21238975. Int J Mol Sci. 2020. PMID: 33255988 Free PMC article. Review.
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.
Forghieri F, Riva G, Lagreca I, Barozzi P, Bettelli F, Paolini A, Nasillo V, Lusenti B, Pioli V, Giusti D, Gilioli A, Colasante C, Galassi L, Catellani H, Donatelli F, Talami A, Maffei R, Martinelli S, Potenza L, Marasca R, Tagliafico E, Manfredini R, Trenti T, Comoli P, Luppi M. Forghieri F, et al. Among authors: comoli p. Int J Mol Sci. 2021 Aug 25;22(17):9159. doi: 10.3390/ijms22179159. Int J Mol Sci. 2021. PMID: 34502069 Free PMC article. Review.
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
Comoli P, Basso S, Riva G, Barozzi P, Guido I, Gurrado A, Quartuccio G, Rubert L, Lagreca I, Vallerini D, Forghieri F, Morselli M, Bresciani P, Cuoghi A, Paolini A, Colaci E, Marasca R, Cuneo A, Iughetti L, Trenti T, Narni F, Foà R, Zecca M, Luppi M, Potenza L. Comoli P, et al. Blood. 2017 Feb 2;129(5):582-586. doi: 10.1182/blood-2016-07-731091. Epub 2016 Dec 7. Blood. 2017. PMID: 27927646 Free PMC article.
Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study.
Galassi L, Colasante C, Bettelli F, Gilioli A, Pioli V, Giusti D, Morselli M, Paolini A, Nasillo V, Lusenti B, Colaci E, Donatelli F, Catellani H, Pozzi S, Barbieri E, Del Rosso MN, Barozzi P, Lagreca I, Martinelli S, Maffei R, Riva G, Tenedini E, Roncati L, Marasca R, Potenza L, Comoli P, Trenti T, Manfredini R, Tagliafico E, Luppi M, Forghieri F. Galassi L, et al. Among authors: comoli p. Leuk Res. 2021 Dec;111:106747. doi: 10.1016/j.leukres.2021.106747. Epub 2021 Nov 9. Leuk Res. 2021. PMID: 34781054 No abstract available.
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity.
Nasillo V, Lagreca I, Vallerini D, Barozzi P, Riva G, Maccaferri M, Paolini A, Forghieri F, Fiorcari S, Maffei R, Martinelli S, Atene CG, Castelli I, Marasca R, Potenza L, Comoli P, Manfredini R, Tagliafico E, Trenti T, Luppi M. Nasillo V, et al. Among authors: comoli p. Cells. 2022 Mar 16;11(6):1003. doi: 10.3390/cells11061003. Cells. 2022. PMID: 35326454 Free PMC article.
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia.
De Cicco M, Lagreca I, Basso S, Barozzi P, Muscianisi S, Bianco A, Riva G, Di Vincenzo S, Pulvirenti C, Sapuppo D, Siciliano M, Rosti V, Candoni A, Zecca M, Forghieri F, Luppi M, Comoli P. De Cicco M, et al. Among authors: comoli p. Cancers (Basel). 2023 May 12;15(10):2731. doi: 10.3390/cancers15102731. Cancers (Basel). 2023. PMID: 37345068 Free PMC article.
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
Forghieri F, Riva G, Lagreca I, Barozzi P, Vallerini D, Morselli M, Paolini A, Bresciani P, Colaci E, Maccaferri M, Gilioli A, Nasillo V, Messerotti A, Pioli V, Arletti L, Giusti D, Bettelli F, Celli M, Donatelli F, Corradini G, Basso S, Gurrado A, Cellini M, Trenti T, Marasca R, Narni F, Martelli MP, Falini B, Potenza L, Luppi M, Comoli P. Forghieri F, et al. Among authors: comoli p. Oncotarget. 2019 Jan 25;10(8):869-882. doi: 10.18632/oncotarget.26617. eCollection 2019 Jan 25. Oncotarget. 2019. PMID: 30783516 Free PMC article.
186 results